MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$13,091K
(42.19%↑ Y/Y)
Loss before income
taxes
-$13,084K
(45.37%↑ Y/Y)
Income tax (expense)
benefit
$7K
(100.54%↑ Y/Y)
Loss from operations
-$11,852K
(51.68%↑ Y/Y)
Total other (expense)
income, net
-$1,232K
(-313.15%↓ Y/Y)
Total revenue
$17,159K
(14.96%↑ Y/Y)
Interest and investment
income, net
$2,084K
(-9.08%↓ Y/Y)
Total operating
expenses
$29,011K
(-26.47%↓ Y/Y)
Interest expense
$3,316K
(93.47%↑ Y/Y)
Research and development
$19,443K
(-30.72%↓ Y/Y)
General and
administrative
$9,568K
(-15.98%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
ENANTA PHARMACEUTICALS INC (ENTA)
ENANTA PHARMACEUTICALS INC (ENTA)